Thermo Fisher Scientific (TMO) Tops Q1 EPS by 2c; Boosts FY15 EPS Midpoint Guidance

Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $1.63, $0.02 better than the analyst estimate of $1.61. Revenue for the quarter came in at $3.92 billion versus the consensus estimate of $4.01 billion.

Thermo Fisher Scientific sees FY2015 EPS of $7.25-$7.40, versus prior guidance of $7.22-$7.40 and the consensus of $7.32. Thermo Fisher Scientific sees FY2015 revenue of $16.67-16.83 billion, versus prior guidance of $16.80-17.00 billion and the consensus of $16.87 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance